• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用马肝微粒体对 GLPG0492 的体外生成代谢物进行兴奋剂控制研究。

Investigation of in vitro generated metabolites of GLPG0492 using equine liver microsomes for doping control.

机构信息

Equine Forensic Unit, Central Veterinary Research Laboratory, Dubai, United Arab Emirates.

Post Graduate and Research Department of Chemistry, Jamal Mohamed College (Affiliated to Bharathidasan University), Tamil Nadu, India.

出版信息

Drug Test Anal. 2023 Jun;15(6):605-628. doi: 10.1002/dta.3453. Epub 2023 Feb 19.

DOI:10.1002/dta.3453
PMID:36762383
Abstract

An effective alternative to testosterone therapy is selective androgen receptor modulators, a class of compounds that has a tissue-specific effect on muscle and bone. These drugs, which enhance performance, pose a severe abuse risk in competitive sports. GLPG0492 is one of the selective androgen receptor modulators discovered in recent decades. This compound has a unique tissue-specific action for muscle and bone against steroid receptors and acts as a partial agonist for androgen receptors. This study examined GLPG0492 and its metabolites in vitro using equine liver microsomes. Liquid chromatography-high-resolution mass spectrometry was utilized to determine the probable structures of detected metabolites. This study identified 39 metabolites of GLPG0492 (21 phase I and 18 phase II). The hydroxylation of GLPG0492 results in monohydroxylated and dihydroxylated metabolites. Additionally, the study detected dissociated side chains (3-methyl and 4-(hydroxymethyl)) and corresponding hydroxylated metabolites. A series of glucuronic acid- and sulfonic acid-conjugated analogs of GLPG0492 were detected during phase II of the study. The findings might help in the detection of GLPG0492 and the elucidation of its illegal use in equestrian sports.

摘要

一种有效的睾酮替代疗法是选择性雄激素受体调节剂,这是一类对肌肉和骨骼具有组织特异性作用的化合物。这些药物可以提高运动表现,在竞技体育中存在严重的滥用风险。GLPG0492 是近几十年来发现的选择性雄激素受体调节剂之一。这种化合物对肌肉和骨骼具有独特的组织特异性作用,对甾体受体具有拮抗作用,对雄激素受体具有部分激动作用。本研究使用马肝微粒体在体外研究了 GLPG0492 及其代谢物。采用液相色谱-高分辨质谱法确定了检测到的代谢物的可能结构。本研究鉴定了 GLPG0492 的 39 种代谢物(21 种 I 相代谢物和 18 种 II 相代谢物)。GLPG0492 的羟化导致单羟化和二羟化代谢物的产生。此外,研究还检测到分离的侧链(3-甲基和 4-(羟甲基))和相应的羟化代谢物。在研究的 II 相中还检测到 GLPG0492 的一系列葡萄糖醛酸和磺酸缀合类似物。这些发现可能有助于检测 GLPG0492 并阐明其在马术运动中的非法使用。

相似文献

1
Investigation of in vitro generated metabolites of GLPG0492 using equine liver microsomes for doping control.使用马肝微粒体对 GLPG0492 的体外生成代谢物进行兴奋剂控制研究。
Drug Test Anal. 2023 Jun;15(6):605-628. doi: 10.1002/dta.3453. Epub 2023 Feb 19.
2
In-depth metabolic study of nonsteroidal selective androgen receptor modulator GSK2881078 in thoroughbred horses and horse liver microsomes for doping control.在纯血马和马肝微粒体中对非甾体类选择性雄激素受体调节剂 GSK2881078 进行深入的代谢研究,用于兴奋剂控制。
Drug Test Anal. 2023 Jul;15(7):757-768. doi: 10.1002/dta.3469. Epub 2023 Mar 27.
3
Metabolic study of selective androgen receptor modulator LY2452473 in thoroughbred horses for doping control.用于兴奋剂检测的纯种马中选择性雄激素受体调节剂LY2452473的代谢研究。
Rapid Commun Mass Spectrom. 2023 May 15;37(9):e9491. doi: 10.1002/rcm.9491.
4
Characterization of equine urinary metabolites of selective androgen receptor modulators (SARMs) S1, S4 and S22 for doping control purposes.用于兴奋剂检测的选择性雄激素受体调节剂(SARM)S1、S4和S22的马尿代谢物表征
Drug Test Anal. 2015 Aug;7(8):673-83. doi: 10.1002/dta.1768. Epub 2015 Jan 5.
5
Identification and Synthesis of Selected In Vitro Generated Metabolites of the Novel Selective Androgen Receptor Modulator (SARM) 2f.新型选择性雄激素受体调节剂(SARM)2f 的鉴定和合成及其在体外生成的代谢物。
Molecules. 2023 Jul 20;28(14):5541. doi: 10.3390/molecules28145541.
6
Identification of equine in vitro metabolites of seven non-steroidal selective androgen receptor modulators for doping control purposes.鉴定七种非甾体选择性雄激素受体调节剂的马体外代谢物,用于兴奋剂控制目的。
Drug Test Anal. 2022 Feb;14(2):349-370. doi: 10.1002/dta.3189. Epub 2021 Dec 10.
7
Equine in vivo metabolite profiling of the selective androgen receptor modulator LGD-3303 for doping control.用于兴奋剂控制的选择性雄激素受体调节剂 LGD-3303 的马体内代谢产物分析。
J Pharm Biomed Anal. 2023 Sep 5;233:115468. doi: 10.1016/j.jpba.2023.115468. Epub 2023 May 18.
8
The fungus Cunninghamella elegans can produce human and equine metabolites of selective androgen receptor modulators (SARMs).线虫状小克银汉霉能够产生选择性雄激素受体调节剂(SARMs)的人体和马体代谢物。
Xenobiotica. 2013 May;43(5):409-20. doi: 10.3109/00498254.2012.729102. Epub 2012 Nov 15.
9
Characterization of a non-approved selective androgen receptor modulator drug candidate sold via the Internet and identification of in vitro generated phase-I metabolites for human sports drug testing.一种通过互联网销售的未经批准的选择性雄激素受体调节剂候选药物的特性鉴定以及用于人体运动药物检测的体外生成的I期代谢物的鉴定。
Rapid Commun Mass Spectrom. 2015 Jun 15;29(11):991-9. doi: 10.1002/rcm.7189.
10
Investigation of in vitro generated metabolites of LGD-4033, a selective androgen receptor modulator, in homogenized camel liver for anti-doping applications.用于反兴奋剂应用的 LGD-4033(一种选择性雄激素受体调节剂)在骆驼肝匀浆中体外生成代谢物的研究。
Rapid Commun Mass Spectrom. 2023 Nov 30;37(22):e9633. doi: 10.1002/rcm.9633.